Theravance Biopharma Inc (TBPH)
EBITDA Margin
65.84%
TTM · Period ending:
TBPH EBITDA Margin
Latest reported65.84%period ending
Latest reported65.84%period ending
TBPH TTM EBITDA Margin (-2886.54% → 65.84%)
TTM ebitda margin
High-resolution chart · PNG
TBPH ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 65.8435% | |
| 129.9376% | |
| 126.3967% | |
| 66.0699% | |
| 59.8912% | |
| -61.7963% | |
| -56.6673% | |
| -53.9024% | |
| -50.283% | |
| -54.3635% | |
| -82.2043% | |
| -98.5213% | |
| -117.023% | |
| -132.0856% | |
| -133.1477% | |
| -178.3301% | |
| -247.0202% | |
| -275.3438% | |
| -369.5413% | |
| -413.4868% | |
| -397.6246% | |
| -401.7282% | |
| -355.1136% | |
| -285.9015% | |
| -299.7969% | |
| -240.2283% | |
| -277.3327% | |
| -328.0695% | |
| -331.387% | |
| -372.0225% | |
| -351.8917% | |
| -489.7514% | |
| -606.8474% | |
| -1,282.0254% | |
| -1,684.2454% | |
| -1,447.5759% | |
| -667.0216% | |
| -580.7082% | |
| -365.3758% | |
| -374.4413% | |
| -482.0077% | |
| -456.1928% | |
| -425.6303% | |
| -476.9727% | |
| -554.634% | |
| -665.0719% | |
| -1,961.5418% | |
| -1,991.1697% | |
| -4,837.6153% | |
| -15,791.6449% | |
| -67,978.3186% | |
| -3,063.5078% | |
| -2,886.5423% |